缺血性卒中后早期肌钙蛋白升高提示心源性栓塞来源
本研究基于前瞻性缺血性卒中数据库,纳入18个月内1234例患者,其中1129例有入院肌钙蛋白数据,10.0%为阳性。校正混杂因素后,肌钙蛋白阳性与不明来源栓塞性卒中(调整OR 4.46,95%CI 1.03-7.97,P=0.003)及心源性栓塞性卒中(OR 5.00,95%CI 1.83-13.63,P=0.002)独立相关。结论提示早期肌钙蛋白升高可能提示心源性栓塞来源。
要点
- 缺血性卒中早期肌钙蛋白阳性与心源性栓塞及不明来源栓塞性卒中独立相关。
- 肌钙蛋白阳性定义为≥0.1 ng/mL,中间值为≥0.06且<0.1 ng/mL。
- 需用高敏肌钙蛋白法验证,并探索阳性患者的二级预防策略。
核心结论
- 缺血性卒中后早期肌钙蛋白阳性可能独立提示心源性栓塞来源。
研究设计与样本
- 前瞻性缺血性卒中数据库研究,18个月内共1234例患者,其中1129例有入院肌钙蛋白数据。
主要发现
- 1129例中10.0%(113/1129)入院肌钙蛋白阳性。
- 完全校正模型中,肌钙蛋白阳性与不明来源栓塞性卒中相关(调整OR 4.46,95%CI 1.03-7.97,P=0.003)。
- 肌钙蛋白阳性与心源性栓塞性卒中相关(OR 5.00,95%CI 1.83-13.63,P=0.002)。
关键数值与推荐
- 肌钙蛋白阳性定义为≥0.1 ng/mL,中间值定义为≥0.06 ng/mL且<0.1 ng/mL。
- 校正因素包括人口学、临床特征、心脏变量及梗死岛叶受累。
临床怎么用
- 对缺血性卒中患者早期检测肌钙蛋白可能有助于提示心源性栓塞来源。
- 肌钙蛋白阳性的不明来源栓塞性卒中患者需进一步评估栓塞来源并优化二级预防。
局限性
- 需未来研究用高敏肌钙蛋白法验证本发现。
- 二级预防策略在肌钙蛋白阳性的不明来源栓塞性卒中患者中尚待测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Elevated cardiac troponin is a marker of cardiac disease and has been recently shown to be associated with embolic stroke risk. We hypothesize that early elevated troponin levels in the acute stroke setting are more prevalent in patients with embolic stroke subtypes (cardioembolic and embolic stroke of unknown source) as opposed to noncardioembolic subtypes (large-vessel disease, small-vessel disease, and other). METHODS: We abstracted data from our prospective ischemic stroke database and included all patients with ischemic stroke during an 18-month period. Per our laboratory, we defined positive troponin as ≥0.1 ng/mL and intermediate as ≥0.06 ng/mL and <0.1 ng/mL. Unadjusted and adjusted regression models were built to determine the association between stroke subtype (embolic stroke of unknown source and cardioembolic subtypes) and positive and intermediate troponin levels, adjusting for key confounders, including demographics (age and sex), clinical characteristics (hypertension, hyperlipidemia, diabetes mellitus, renal function, coronary heart disease, congestive heart failure, current smoking, and National Institutes of Health Stroke Scale score), cardiac variables (left atrial diameter, wall-motion abnormalities, ejection fraction, and PR interval on ECG), and insular involvement of infarct. RESULTS: We identified 1234 patients, of whom 1129 had admission troponin levels available; 10.0% (113/1129) of these had a positive troponin. In fully adjusted models, there was an association between troponin positivity and embolic stroke of unknown source subtype (adjusted odds ratio, 4.46; 95% confidence interval, 1.03-7.97; P=0.003) and cardioembolic stroke subtype (odds ratio, 5.00; 95% confidence interval, 1.83-13.63; P=0.002). CONCLUSIONS: We found that early positive troponin after ischemic stroke may be independently associated with a cardiac embolic source. Future studies are needed to confirm our findings using high-sensitivity troponin assays and to test optimal secondary prevention strategies in patients with embolic stroke of unknown source and positive troponin.
引用
- Yaghi S, Chang AD, Ricci BA, et al. Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source. Stroke. 2017. PMID: 29167390. doi:10.1161/STROKEAHA.117.019395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。